Hope for PSP: experimental drug AMX0035 tested in major trial
Disease control
Completed
This study tested an experimental drug called AMX0035 in 139 people with progressive supranuclear palsy (PSP), a rare brain disease that affects movement and balance. The goal was to see if the drug could slow down the disease. Participants received either the drug or a placebo, …
Phase: PHASE2, PHASE3 • Sponsor: Amylyx Pharmaceuticals Inc. • Aim: Disease control
Last updated May 01, 2026 23:44 UTC